VIVUS to Present at Upcoming Investor Conference
12 juin 2013 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., June 12, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at the following investment...
New Article Discusses Treatment Options for Weight Management in People With Type 2 Diabetes
07 juin 2013 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., June 7, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that a review article has been published online in The Journal of Diabetes and Its Complications...
VIVUS Files Definitive Proxy Materials With SEC
05 juin 2013 13h45 HE
|
VIVUS, Inc.
Urges Stockholders to Vote FOR the Board's Nominees on GOLD Proxy Card Today
Dissidents' Actions Jeopardize VIVUS's Progress at Critical Time
MOUNTAIN VIEW, Calif., June 5, 2013 (GLOBE NEWSWIRE)...
VIVUS Announces Scientific Presentations
03 juin 2013 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., June 3, 2013 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
VIVUS Announces Scientific Presentations
22 mai 2013 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., May 22, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
VIVUS Announces Pricing of Offering of $220 Million of 4.50% Convertible Senior Notes
16 mai 2013 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., May 16, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) announced today the pricing of its offering of $220 million aggregate principal amount of 4.50% convertible senior...
VIVUS Announces Proposed Offering of Convertible Senior Notes
15 mai 2013 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., May 15, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) announced today that it intends to offer, subject to market and other conditions, $200 million aggregate principal...
VIVUS Announces Scientific Presentations
14 mai 2013 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
VIVUS Mails Letter to Stockholders Providing Business Update
13 mai 2013 07h05 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., May 13, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company") today mailed a letter to stockholders providing an update on the Company's recent progress. The full...
VIVUS Appoints J. Martin Carroll and Jorge Plutzky, M.D. to Board of Directors
13 mai 2013 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., May 13, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced the appointment of J. Martin Carroll and Jorge Plutzky, M.D. to its Board of Directors.
Mr. Carroll...